التميّز في صحة العين
20,000+ إجراء

B1. OĞUREL M.B., Cebeci Z., Çukurova S.N., İnce B., Artım E.B. (2020). Evaluation of systemic lupus erythematosus patients who discontinued hydroxychloroquine treatment using multimodal assessment, Turkish Ophthalmological Association 2020 virtual national congress and live surgery joint meeting.

B2. OĞUREL M.B., Oray M., Tuğal Tutkun İ. (2021). The impact of the COVID-19 pandemic on the follow-up and treatment of uveitis patients, Turkish Ophthalmological Association Virtual 43rd Spring Symposium.

B3. OĞUREL M.B., Bayraktar Ş., Özbilen K.T., İzgi B. (2021). Efficacy and safety of transscleral diode laser cyclophotocoagulation in refractory glaucoma cases with good visual acuity, Turkish Ophthalmological Association 2021 National Congress.

B4. OĞUREL M.B., Aksu C.N. (2021). Evaluation of macular and optic disc head vascular density in amblyopic patients using optical coherence tomography angiography, Turkish Ophthalmological Association 34th Summer Symposium.

B5. İnce B., OĞUREL M.B., Cebeci Z., Tor Y.B., Uçar H.B., Şahinkaya Y., Gül A., İnaç M., Esen B.A. (2022). The effect of hydroxychloroquine on disease activity in SLE and the role of multimodal imaging methods in diagnosing retinal toxicity, Target in Rheumatology 2022 Symposium.

B6. Öksüz L., Al Hamwi R., Özbilen K.T., OĞUREL M.B., Aktaş Z. (2019). Microorganisms isolated from ocular infections over a two-year period and their antibiotic resistance profiles, KLİMİK Congress, 13–16 March 2019.

B7. Bağrıova P., Hatemi A.İ., Eşkazan T., OĞUREL M.B. (2023). Frequency of Sjögren’s syndrome in patients with primary biliary cholangitis, 25th National Congress of Internal Medicine.